Agilent Technologies, Inc. $A Shares Sold by Eurizon Capital SGR S.p.A.

Eurizon Capital SGR S.p.A. decreased its stake in Agilent Technologies, Inc. (NYSE:A – Free Report) by 5.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 195,626 shares of the medical research company’s stock after selling 11,192 shares during the quarter. Eurizon Capital SGR S.p.A. owned about 0.07% of Agilent Technologies worth $33,738,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Bank of Nova Scotia purchased a new position in shares of Agilent Technologies during the second quarter valued at approximately $58,539,000. Dudley & Shanley Inc. grew its stake in shares of Agilent Technologies by 25.9% during the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after buying an additional 14,300 shares during the last quarter. BIP Wealth LLC purchased a new stake in shares of Agilent Technologies in the second quarter worth approximately $834,000. Sivia Capital Partners LLC purchased a new stake in shares of Agilent Technologies in the second quarter worth approximately $1,818,000. Finally, KBC Group NV lifted its stake in shares of Agilent Technologies by 18.4% during the 2nd quarter. KBC Group NV now owns 81,883 shares of the medical research company’s stock worth $10,877,000 after acquiring an additional 12,719 shares during the last quarter.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director directly owned 4,924 shares in the company, valued at $745,395.12. This represents a 11.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Analysts Set New Price Targets

A has been the subject of a number of recent analyst reports. Bank of America boosted their price objective on Agilent Technologies from $180.00 to $190.00 in a report on Friday, October 9th. JPMorgan Chase & Co. increased their target price on Agilent Technologies from $190.00 to $195.00 in a research note on Wednesday, October 14th. Citigroup lifted their target price on Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Wells Fargo & Company boosted their target price on shares of Agilent Technologies from $160.00 to $180.00 and gave the company an “overweight” rating in a research note on Friday, August 28th. Finally, Rothschild & Co Redburn upped their price target on shares of Agilent Technologies from $160.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, August 27th. Eighteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $181.45.

Get Our Latest Stock Report on Agilent Technologies

Agilent Technologies Trading Up 0.6%

A opened at $173.99 on Friday. The stock’s fifty day moving average is $168.41 and its two-hundred day moving average is $138.19. The company has a market capitalization of $49.05 billion, a P/E ratio of 28.55, a PEG ratio of 2.53 and a beta of 1.24. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $182.99. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A – Get Free Report) last issued its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. During the same period in the prior year, the business earned $1.37 EPS. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts forecast that Agilent Technologies, Inc. will post 6.20 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th were paid a $0.2550 dividend. The ex-dividend date of this dividend was Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a yield of 0.6%. Agilent Technologies’s dividend payout ratio is 20.08%.

Agilent Technologies Profile

(Free Report)

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Read More

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.